4 views left Get unlimited views with a free account

Subscribe to GlobalData Explorer

Explore the latest trends and actionable insights on the COVID-19 Tests market to inform business strategy and pinpoint opportunities and risks

COVID-19 Test Kits Market

Industry: Infectious Disease
Current: Market Sizing & Shares

COVID-19 pandemic has led to the emergence and development of nucleic acid amplification test (NAAT) and RT-PCR tests to detect the presence of viral genetic material in the patient’s sample
In 2021, APAC was the largest regional contributor for COVID-19 Tests acquiring 69% of the market by value
Globally, the COVID-19 PCR Test market is dominated by Roche and Abbott

COVID-19 Pandemic necessitates the global demand for diagnostic tests

As per GlobalData’s Medical Device database, the APAC region tops the COVID-19 tests market contributing 69% of the total market by value. In North America, the US recorded the significant market size in 2021, while in Europe, South Central America, and MEA region, the countries that topped the market size in 2021 are the UK, Brazil, and Israel, respectively.

Severe Acute Respiratory Syndrome Coronavirus, SARS‐CoV‐2, is a novel coronavirus that has spread worldwide, leading the World Health Organization (WHO) to declare it a pandemic. To detect the virus, a nucleic acid amplification test (NAAT) and RT-PCR tests are used to detect the presence of viral genetic material in the patient’s sample. NAAT had been a choice of testing during the initial phase of the pandemic, but currently, RT-PCR tests are used widely because of their flexible price, ease throughout, and other features.

As per GlobalData’s COVID database, as of April 25, 2022, there were in total 509,909,397 confirmed cases of COVID-19, with 6,219,996 deaths recorded worldwide. At a global level, approximately 11.5 billion people had been vaccinated against the COVID-19 with the immunization rate being higher than 70% in the developed nations.

Major companies dominating the IVD market for COVID-19 Tests

Roche, Abbott, Hologic, Becton Dickinson and co, DiaSorin, and bioMerieux dominate the COVID-19 test market, covering more than 50% by value.

Both Roche and Abbott dominate the COVID-19 PCR Test market due to their strong sales of COVID-19 NAATs across all geographical regions. NAATs market is dominated by Roche, closely followed by Hologic. In contrast, the Multiplex NAATs market is dominated by bioMerieux, which covers more than 90% of the market. These major players manufacturing COVID-19 Test Kits may wish to focus their product outreach, and marketing efforts on countries and spend more on R&D for COVID-19 diagnostic techniques, which might help in less time-consuming and accurate diagnostic tests.

Growing uncertainty in COVID-19 Tests market amid new surge in COVID-19 cases in parallel with increase vaccinations

COVID-19 directed the growth, advancement, and extensive usage of technologies to detect COVID-19. According to GlobalData, with the increasing public awareness, immunization coverage, distribution of booster doses, ongoing clinical trials, and a shift toward rapid antigen detection tests (RADTs) and Point-of-Care (POC) testing, the market size of RT-PCR tests is expected to decrease in the coming years.

Furthermore, precautions for COVID-19 resulted in a severely reduced flu season during 2020-2021. Although public health measures, including mask mandates and social distancing measures, have been relaxed, the potential for flu infection to return is creating awareness among the people towards adapting self-precautionary standards. Owing to physician preference, the use of multiplex NAATs seen in 2020 and 2021 is expected to continue for 2022.

Several nations after controlling the spread of COVID-19 are re-opening their borders for tourism and travel. With the pandemic still very much a global issue, the re-opening of borders makes it vulnerable to spread of COVID-19 again and require the need for testing.

Explore the latest trends and actionable insights on the COVID-19 Tests market to inform business strategy and pinpoint opportunities and risks Explore the latest trends and actionable insights on the COVID-19 Tests market to inform business strategy and pinpoint opportunities and risks Visit Report Store